These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29901239)

  • 1. The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV
    Hoo ZH; Curley R; Campbell MJ; Walters SJ; Wildman MJ
    J Eval Clin Pract; 2018 Aug; 24(4):745-751. PubMed ID: 29901239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding FEV
    Hoo ZH; Campbell MJ; Walters SJ; Wildman MJ
    J Eval Clin Pract; 2020 Feb; 26(1):229-235. PubMed ID: 30681238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?
    Nightingale JA; Osmond C
    J Cyst Fibros; 2017 Sep; 16(5):585-591. PubMed ID: 28462874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.
    Schlüter DK; Southern KW; Dryden C; Diggle P; Taylor-Robinson D
    Thorax; 2020 Feb; 75(2):123-131. PubMed ID: 31771956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CF.
    Hoo ZH; Wildman MJ; Curley R; Walters SJ; Campbell MJ
    Respirology; 2018 Feb; 23(2):190-197. PubMed ID: 28905459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children and young adults with CF in the USA have better lung function compared with the UK.
    Goss CH; MacNeill SJ; Quinton HB; Marshall BC; Elbert A; Knapp EA; Petren K; Gunn E; Osmond J; Bilton D
    Thorax; 2015 Mar; 70(3):229-36. PubMed ID: 25256255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cystic fibrosis centres with the lowest FEV
    Hoo ZH; Campbell MJ; Curley R; Walters SJ; Wildman MJ
    J Cyst Fibros; 2018 May; 17(3):360-367. PubMed ID: 29074367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry.
    Stanojevic S; Stocks J; Bountziouka V; Aurora P; Kirkby J; Bourke S; Carr SB; Gunn E; Prasad A; Rosenfeld M; Bilton D
    J Cyst Fibros; 2014 May; 13(3):319-27. PubMed ID: 24332996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study.
    Taylor-Robinson DC; Smyth RL; Diggle PJ; Whitehead M
    Lancet Respir Med; 2013 Apr; 1(2):121-8. PubMed ID: 24429092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries.
    Kim SO; Corey M; Stephenson AL; Strug LJ
    Thorax; 2018 May; 73(5):446-450. PubMed ID: 29434047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous antibiotic use and exacerbation events in an adult cystic fibrosis centre: A prospective observational study.
    Hoo ZH; Bramley NR; Curley R; Edenborough FP; Walters SJ; Campbell MJ; Wildman MJ
    Respir Med; 2019; 154():109-115. PubMed ID: 31234038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Italian Cystic Fibrosis Register - Report 2010].
    Amato A; Ferrigno L; Salvatore M; Toccaceli V;
    Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry.
    Caley L; Smith L; White H; Peckham DG
    J Cyst Fibros; 2021 Jan; 20(1):86-90. PubMed ID: 32381400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explaining the Sex Effect on Survival in Cystic Fibrosis: a Joint Modeling Study of UK Registry Data.
    Taylor-Robinson D; Schlüter DK; Diggle PJ; Barrett JK
    Epidemiology; 2020 Nov; 31(6):872-879. PubMed ID: 32841985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in lung function and nutritional decline in cystic fibrosis by genotype: An analysis of the Canadian cystic fibrosis registry.
    Leung GJ; Cho TJ; Kovesi T; Hamid JS; Radhakrishnan D
    J Cyst Fibros; 2020 Mar; 19(2):255-261. PubMed ID: 31253541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Italian Cystic Fibrosis Registry. Report 2011-2014].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.